);
Contacteer ons
LinkedIn Post 1
October 2025

All eyes on Fertiga in Women’s Health Week Europe 2025!

We’re thrilled to announce that Fertiga is selected to pitch at the Med Device & Therapeutics Innovation Showcase during Women’s Health Week Europe 2025 on 17 October!

Our presentation in the ‘Clinical, Diagnostic, or Treatment-based’ category will spotlight how Fertiga is redefining fertility care through science and innovation. A fantastic opportunity to connect with investors, pharma leaders, and health systems shaping the future of women’s health. 🌍💡

LinkedIn Post 1
May 2025

All eyes on Fertiga in EMD Serono Corporate Accelerator!

We’re thrilled to share that Fertiga has been selected to pitch at Women’s Health Week (previously SiS) in New York 2025 as part of the EMD Serono Corporate Accelerator (ESCA)! It’s an honour to join a select group of innovators driving change in reproductive health, with the support of EMD Serono, Inc. and M Ventures.


LinkedIn Post 1
April 2025

All eyes on Fertiga in Women’s Health during BioTrinity 2025!!

We are proud to present our innovative fertility tests at the ‘Women’s Health’ Spotlight during BioTrinity 2025 in London, UK.

BioTrinity is an event organised by OBN (UK) Ltd, that brings together the life science community, and we are proud to attend and showcase Fertiga’s innovative Aurora Test. This is a fantastic opportunity to connect, collaborate, and explore new business opportunities in the UK.